APO Research
Talk to an analyst

APO RESEARCH · REPORT

External Anti-infective Preparations

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global External Anti-infective Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025195 pages

Choose your research edition.

Industry ResearchExternal Anti-infective Preparations Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal External Anti-infective Preparations Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal External Anti-infective Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal External Anti-infective Preparations Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal External Anti-infective Preparations Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global External Anti-infective Preparations market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for External Anti-infective Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of External Anti-infective Preparations include SK-SF, Zhejiang Funo Pharmaceuticals, Teva, Sun Pharmaceutical, Shandong Jingwei Pharmaceuticals, Sandoz, J & J, Liaoning Xingao Pharmaceuticals and Jiangsu Zhiyuan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global External Anti-infective Preparations market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of External Anti-infective Preparations and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents External Anti-infective Preparations revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the External Anti-infective Preparations market size, projected growth trends, production technologies, key applications, and end-use industries.

External Anti-infective Preparations Segment by Company

SK-SF

Zhejiang Funo Pharmaceuticals

Teva

Sun Pharmaceutical

Shandong Jingwei Pharmaceuticals

Sandoz

J & J

Liaoning Xingao Pharmaceuticals

Jiangsu Zhiyuan Pharmaceuticals

Jiangsu Fubang Pharmaceuticals

Hubei Renfu

Bayer

STADA Arzneimittel

LEO Pharma

Kaken Pharmaceutical

Haleon

Glenmark Pharmaceuticals

Galderma

Bausch Health

Almirall

External Anti-infective Preparations Segment by Type

Ointment

Solution

Gel

Other

External Anti-infective Preparations Segment by Application

Hospital

Retail Phamracy

Other

External Anti-infective Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global External Anti-infective Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of External Anti-infective Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of External Anti-infective Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of External Anti-infective Preparations in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global External Anti-infective Preparations industry.

Chapter 3: Detailed analysis of External Anti-infective Preparations companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, External Anti-infective Preparationsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global External Anti-infective Preparations Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ointment Table 3. Key Players of Solution Table 4. Key Players of Gel Table 3. Key Players of Other Table 4. Global External Anti-infective Preparations Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Phamracy Table 7. Key Players of Other Table 8. Global External Anti-infective Preparations Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global External Anti-infective Preparations Market Size by Region (2021-2026) & (US$ Million) Table 10. Global External Anti-infective Preparations Market Share by Region (2021-2026) Table 11. Global External Anti-infective Preparations Market Size by Region (2027-2032) & (US$ Million) Table 12. Global External Anti-infective Preparations Market Share by Region (2027-2032) Table 13. External Anti-infective Preparations Industry Trends Table 14. External Anti-infective Preparations Industry Drivers Table 15. External Anti-infective Preparations Industry Opportunities and Challenges Table 16. External Anti-infective Preparations Industry Restraints Table 17. Global External Anti-infective Preparations Revenue by Company (US$ Million) & (2021-2026) Table 18. Global External Anti-infective Preparations Revenue Market Share by Company (2021-2026) Table 19. Global External Anti-infective Preparations Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global External Anti-infective Preparations Key Company Head Office and Area Served Table 21. Global External Anti-infective Preparations Company, Product Type & Application Table 22. Global External Anti-infective Preparations Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global External Anti-infective Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global External Anti-infective Preparations Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 27. Global External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 28. Global External Anti-infective Preparations Revenue Market Share by Type (2021-2026) Table 29. Global External Anti-infective Preparations Revenue Market Share by Type (2027-2032) Table 30. Global External Anti-infective Preparations Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 32. Global External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 33. Global External Anti-infective Preparations Revenue Market Share by Application (2021-2026) Table 34. Global External Anti-infective Preparations Revenue Market Share by Application (2027-2032) Table 35. SK-SF Company Information Table 36. SK-SF Business Overview Table 37. SK-SF External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. SK-SF External Anti-infective Preparations Product Portfolio Table 39. SK-SF Recent Development Table 40. Zhejiang Funo Pharmaceuticals Company Information Table 41. Zhejiang Funo Pharmaceuticals Business Overview Table 42. Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 44. Zhejiang Funo Pharmaceuticals Recent Development Table 45. Teva Company Information Table 46. Teva Business Overview Table 47. Teva External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Teva External Anti-infective Preparations Product Portfolio Table 49. Teva Recent Development Table 50. Sun Pharmaceutical Company Information Table 51. Sun Pharmaceutical Business Overview Table 52. Sun Pharmaceutical External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sun Pharmaceutical External Anti-infective Preparations Product Portfolio Table 54. Sun Pharmaceutical Recent Development Table 55. Shandong Jingwei Pharmaceuticals Company Information Table 56. Shandong Jingwei Pharmaceuticals Business Overview Table 57. Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 59. Shandong Jingwei Pharmaceuticals Recent Development Table 60. Sandoz Company Information Table 61. Sandoz Business Overview Table 62. Sandoz External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sandoz External Anti-infective Preparations Product Portfolio Table 64. Sandoz Recent Development Table 65. J & J Company Information Table 66. J & J Business Overview Table 67. J & J External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. J & J External Anti-infective Preparations Product Portfolio Table 69. J & J Recent Development Table 70. Liaoning Xingao Pharmaceuticals Company Information Table 71. Liaoning Xingao Pharmaceuticals Business Overview Table 72. Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 74. Liaoning Xingao Pharmaceuticals Recent Development Table 75. Jiangsu Zhiyuan Pharmaceuticals Company Information Table 76. Jiangsu Zhiyuan Pharmaceuticals Business Overview Table 77. Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 79. Jiangsu Zhiyuan Pharmaceuticals Recent Development Table 80. Jiangsu Fubang Pharmaceuticals Company Information Table 81. Jiangsu Fubang Pharmaceuticals Business Overview Table 82. Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 84. Jiangsu Fubang Pharmaceuticals Recent Development Table 85. Hubei Renfu Company Information Table 86. Hubei Renfu Business Overview Table 87. Hubei Renfu External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Hubei Renfu External Anti-infective Preparations Product Portfolio Table 89. Hubei Renfu Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bayer External Anti-infective Preparations Product Portfolio Table 94. Bayer Recent Development Table 95. STADA Arzneimittel Company Information Table 96. STADA Arzneimittel Business Overview Table 97. STADA Arzneimittel External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. STADA Arzneimittel External Anti-infective Preparations Product Portfolio Table 99. STADA Arzneimittel Recent Development Table 100. LEO Pharma Company Information Table 101. LEO Pharma Business Overview Table 102. LEO Pharma External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. LEO Pharma External Anti-infective Preparations Product Portfolio Table 104. LEO Pharma Recent Development Table 105. Kaken Pharmaceutical Company Information Table 106. Kaken Pharmaceutical Business Overview Table 107. Kaken Pharmaceutical External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Kaken Pharmaceutical External Anti-infective Preparations Product Portfolio Table 109. Kaken Pharmaceutical Recent Development Table 110. Haleon Company Information Table 111. Haleon Business Overview Table 112. Haleon External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Haleon External Anti-infective Preparations Product Portfolio Table 114. Haleon Recent Development Table 115. Glenmark Pharmaceuticals Company Information Table 116. Glenmark Pharmaceuticals Business Overview Table 117. Glenmark Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Glenmark Pharmaceuticals External Anti-infective Preparations Product Portfolio Table 119. Glenmark Pharmaceuticals Recent Development Table 120. Galderma Company Information Table 121. Galderma Business Overview Table 122. Galderma External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Galderma External Anti-infective Preparations Product Portfolio Table 124. Galderma Recent Development Table 125. Bausch Health Company Information Table 126. Bausch Health Business Overview Table 127. Bausch Health External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Bausch Health External Anti-infective Preparations Product Portfolio Table 129. Bausch Health Recent Development Table 130. Almirall Company Information Table 131. Almirall Business Overview Table 132. Almirall External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Almirall External Anti-infective Preparations Product Portfolio Table 134. Almirall Recent Development Table 135. North America External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 136. North America External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 137. North America External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 138. North America External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 139. North America External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America External Anti-infective Preparations Market Size by Country (2021-2026) Table 141. North America External Anti-infective Preparations Market Size by Country (2027-2032) Table 142. Europe External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 143. Europe External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 144. Europe External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 145. Europe External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 146. Europe External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe External Anti-infective Preparations Market Size by Country (2021-2026) Table 148. Europe External Anti-infective Preparations Market Size by Country (2027-2032) Table 149. China External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 150. China External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 151. China External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 152. China External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 154. Asia External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 155. Asia External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 156. Asia External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia External Anti-infective Preparations Market Size by Country (2021-2026) Table 159. Asia External Anti-infective Preparations Market Size by Country (2027-2032) Table 160. South America, Middle East & Africa External Anti-infective Preparations Market Size by Type (2021-2026) & (US$ Million) Table 161. South America, Middle East & Africa External Anti-infective Preparations Market Size by Type (2027-2032) & (US$ Million) Table 162. South America, Middle East & Africa External Anti-infective Preparations Market Size by Application (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa External Anti-infective Preparations Market Size by Application (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2021-2026) Table 166. South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. External Anti-infective Preparations Product Image Figure 2. Global External Anti-infective Preparations Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global External Anti-infective Preparations Market Share by Type: 2025 VS 2032 Figure 4. Ointment Image Figure 5. Solution Image Figure 6. Gel Image Figure 7. Other Image Figure 8. Global External Anti-infective Preparations Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global External Anti-infective Preparations Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Phamracy Image Figure 12. Other Image Figure 13. Global External Anti-infective Preparations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 15. Global External Anti-infective Preparations Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global External Anti-infective Preparations Market Share by Players in 2025 Figure 18. Global Top 5 and 10 External Anti-infective Preparations Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global External Anti-infective Preparations Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global External Anti-infective Preparations Revenue Market Share by Type (2021-2032) Figure 22. Global External Anti-infective Preparations Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global External Anti-infective Preparations Revenue Market Share by Application (2021-2032) Figure 24. North America External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 25. North America External Anti-infective Preparations Market Share by Type (2021-2032) Figure 26. North America External Anti-infective Preparations Market Share by Application (2021-2032) Figure 27. North America External Anti-infective Preparations Market Share by Country (2021-2032) Figure 28. United States External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 29. Canada External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 30. Mexico External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 31. Europe External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 32. Europe External Anti-infective Preparations Market Share by Type (2021-2032) Figure 33. Europe External Anti-infective Preparations Market Share by Application (2021-2032) Figure 34. Europe External Anti-infective Preparations Market Share by Country (2021-2032) Figure 35. Germany External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 36. France External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 37. U.K. External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 38. Italy External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 39. Russia External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 41. China External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 42. China External Anti-infective Preparations Market Share by Type (2021-2032) Figure 43. China External Anti-infective Preparations Market Share by Application (2021-2032) Figure 44. Asia External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 45. Asia External Anti-infective Preparations Market Share by Type (2021-2032) Figure 46. Asia External Anti-infective Preparations Market Share by Application (2021-2032) Figure 47. Asia External Anti-infective Preparations Market Share by Country (2021-2032) Figure 48. Japan External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 49. South Korea External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 52. India External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 53. Australia External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa External Anti-infective Preparations Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa External Anti-infective Preparations Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa External Anti-infective Preparations Market Share by Country (2021-2032) Figure 58. Brazil External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 59. South Africa External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 61. Turkey External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 62. Argentina External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 63. UAE External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 64. Egypt External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 65. Chile External Anti-infective Preparations Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Ointment
  • Solution
  • Gel
  • Other
Applications
  • Hospital
  • Retail Phamracy
  • Other
Companies covered
  • SK-SF
  • Zhejiang Funo Pharmaceuticals
  • Teva
  • Sun Pharmaceutical
  • Shandong Jingwei Pharmaceuticals
  • Sandoz
  • J & J
  • Liaoning Xingao Pharmaceuticals
  • Jiangsu Zhiyuan Pharmaceuticals
  • Jiangsu Fubang Pharmaceuticals
  • Hubei Renfu
  • Bayer
  • STADA Arzneimittel
  • LEO Pharma
  • Kaken Pharmaceutical
  • Haleon
  • Glenmark Pharmaceuticals
  • Galderma
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global External Anti-infective Preparations Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ointment
  5. 1.2.3 Solution
  6. 1.2.4 Gel
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global External Anti-infective Preparations Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Phamracy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global External Anti-infective Preparations Growth Trends by Region
  15. 1.5.1 Global External Anti-infective Preparations Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 External Anti-infective Preparations Market Size by Region (2021-2026)
  17. 1.5.3 External Anti-infective Preparations Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global External Anti-infective Preparations Market Dynamics
  1. 2.1 External Anti-infective Preparations Industry Trends
  2. 2.2 External Anti-infective Preparations Industry Drivers
  3. 2.3 External Anti-infective Preparations Industry Opportunities and Challenges
  4. 2.4 External Anti-infective Preparations Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global External Anti-infective Preparations Revenue by Company (2021-2026)
  2. 3.2 Global External Anti-infective Preparations Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global External Anti-infective Preparations Key Company Head office and Area Served
  4. 3.4 Global External Anti-infective Preparations Company, Product Type & Application
  5. 3.5 Global External Anti-infective Preparations Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global External Anti-infective Preparations Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 External Anti-infective Preparations Players Market Share by Revenue in 2025
  9. 3.6.3 2025 External Anti-infective Preparations Tier 1, Tier 2, and Tier 3
4 External Anti-infective Preparations Market by Type
  1. 4.1 Global External Anti-infective Preparations Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global External Anti-infective Preparations Market Size by Type (2021-2032)
  3. 4.3 Global External Anti-infective Preparations Market Size Share by Type (2021-2032)
5 External Anti-infective Preparations Market by Application
  1. 5.1 Global External Anti-infective Preparations Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global External Anti-infective Preparations Market Size by Application (2021-2032)
  3. 5.3 Global External Anti-infective Preparations Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 SK-SF
  2. 6.1.1 SK-SF Company Information
  3. 6.1.2 SK-SF Business Overview
  4. 6.1.3 SK-SF External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 SK-SF External Anti-infective Preparations Product Portfolio
  6. 6.1.5 SK-SF Recent Developments
  7. 6.2 Zhejiang Funo Pharmaceuticals
  8. 6.2.1 Zhejiang Funo Pharmaceuticals Company Information
  9. 6.2.2 Zhejiang Funo Pharmaceuticals Business Overview
  10. 6.2.3 Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zhejiang Funo Pharmaceuticals External Anti-infective Preparations Product Portfolio
  12. 6.2.5 Zhejiang Funo Pharmaceuticals Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Teva External Anti-infective Preparations Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sun Pharmaceutical External Anti-infective Preparations Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Shandong Jingwei Pharmaceuticals
  26. 6.5.1 Shandong Jingwei Pharmaceuticals Company Information
  27. 6.5.2 Shandong Jingwei Pharmaceuticals Business Overview
  28. 6.5.3 Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shandong Jingwei Pharmaceuticals External Anti-infective Preparations Product Portfolio
  30. 6.5.5 Shandong Jingwei Pharmaceuticals Recent Developments
  31. 6.6 Sandoz
  32. 6.6.1 Sandoz Company Information
  33. 6.6.2 Sandoz Business Overview
  34. 6.6.3 Sandoz External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sandoz External Anti-infective Preparations Product Portfolio
  36. 6.6.5 Sandoz Recent Developments
  37. 6.7 J & J
  38. 6.7.1 J & J Company Information
  39. 6.7.2 J & J Business Overview
  40. 6.7.3 J & J External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 J & J External Anti-infective Preparations Product Portfolio
  42. 6.7.5 J & J Recent Developments
  43. 6.8 Liaoning Xingao Pharmaceuticals
  44. 6.8.1 Liaoning Xingao Pharmaceuticals Company Information
  45. 6.8.2 Liaoning Xingao Pharmaceuticals Business Overview
  46. 6.8.3 Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Liaoning Xingao Pharmaceuticals External Anti-infective Preparations Product Portfolio
  48. 6.8.5 Liaoning Xingao Pharmaceuticals Recent Developments
  49. 6.9 Jiangsu Zhiyuan Pharmaceuticals
  50. 6.9.1 Jiangsu Zhiyuan Pharmaceuticals Company Information
  51. 6.9.2 Jiangsu Zhiyuan Pharmaceuticals Business Overview
  52. 6.9.3 Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Jiangsu Zhiyuan Pharmaceuticals External Anti-infective Preparations Product Portfolio
  54. 6.9.5 Jiangsu Zhiyuan Pharmaceuticals Recent Developments
  55. 6.10 Jiangsu Fubang Pharmaceuticals
  56. 6.10.1 Jiangsu Fubang Pharmaceuticals Company Information
  57. 6.10.2 Jiangsu Fubang Pharmaceuticals Business Overview
  58. 6.10.3 Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Jiangsu Fubang Pharmaceuticals External Anti-infective Preparations Product Portfolio
  60. 6.10.5 Jiangsu Fubang Pharmaceuticals Recent Developments
  61. 6.11 Hubei Renfu
  62. 6.11.1 Hubei Renfu Company Information
  63. 6.11.2 Hubei Renfu Business Overview
  64. 6.11.3 Hubei Renfu External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hubei Renfu External Anti-infective Preparations Product Portfolio
  66. 6.11.5 Hubei Renfu Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bayer External Anti-infective Preparations Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 STADA Arzneimittel
  74. 6.13.1 STADA Arzneimittel Company Information
  75. 6.13.2 STADA Arzneimittel Business Overview
  76. 6.13.3 STADA Arzneimittel External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 STADA Arzneimittel External Anti-infective Preparations Product Portfolio
  78. 6.13.5 STADA Arzneimittel Recent Developments
  79. 6.14 LEO Pharma
  80. 6.14.1 LEO Pharma Company Information
  81. 6.14.2 LEO Pharma Business Overview
  82. 6.14.3 LEO Pharma External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 LEO Pharma External Anti-infective Preparations Product Portfolio
  84. 6.14.5 LEO Pharma Recent Developments
  85. 6.15 Kaken Pharmaceutical
  86. 6.15.1 Kaken Pharmaceutical Company Information
  87. 6.15.2 Kaken Pharmaceutical Business Overview
  88. 6.15.3 Kaken Pharmaceutical External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Kaken Pharmaceutical External Anti-infective Preparations Product Portfolio
  90. 6.15.5 Kaken Pharmaceutical Recent Developments
  91. 6.16 Haleon
  92. 6.16.1 Haleon Company Information
  93. 6.16.2 Haleon Business Overview
  94. 6.16.3 Haleon External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Haleon External Anti-infective Preparations Product Portfolio
  96. 6.16.5 Haleon Recent Developments
  97. 6.17 Glenmark Pharmaceuticals
  98. 6.17.1 Glenmark Pharmaceuticals Company Information
  99. 6.17.2 Glenmark Pharmaceuticals Business Overview
  100. 6.17.3 Glenmark Pharmaceuticals External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Glenmark Pharmaceuticals External Anti-infective Preparations Product Portfolio
  102. 6.17.5 Glenmark Pharmaceuticals Recent Developments
  103. 6.18 Galderma
  104. 6.18.1 Galderma Company Information
  105. 6.18.2 Galderma Business Overview
  106. 6.18.3 Galderma External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Galderma External Anti-infective Preparations Product Portfolio
  108. 6.18.5 Galderma Recent Developments
  109. 6.19 Bausch Health
  110. 6.19.1 Bausch Health Company Information
  111. 6.19.2 Bausch Health Business Overview
  112. 6.19.3 Bausch Health External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Bausch Health External Anti-infective Preparations Product Portfolio
  114. 6.19.5 Bausch Health Recent Developments
  115. 6.20 Almirall
  116. 6.20.1 Almirall Company Information
  117. 6.20.2 Almirall Business Overview
  118. 6.20.3 Almirall External Anti-infective Preparations Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Almirall External Anti-infective Preparations Product Portfolio
  120. 6.20.5 Almirall Recent Developments
7 North America
  1. 7.1 North America External Anti-infective Preparations Market Size (2021-2032)
  2. 7.2 North America External Anti-infective Preparations Market Size by Type
  3. 7.2.1 North America External Anti-infective Preparations Market Size by Type (2021-2026)
  4. 7.2.2 North America External Anti-infective Preparations Market Size by Type (2027-2032)
  5. 7.2.3 North America External Anti-infective Preparations Market Share by Type (2021-2032)
  6. 7.3 North America External Anti-infective Preparations Market Size by Application
  7. 7.3.1 North America External Anti-infective Preparations Market Size by Application (2021-2026)
  8. 7.3.2 North America External Anti-infective Preparations Market Size by Application (2027-2032)
  9. 7.3.3 North America External Anti-infective Preparations Market Share by Application (2021-2032)
  10. 7.4 North America External Anti-infective Preparations Market Size by Country
  11. 7.4.1 North America External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America External Anti-infective Preparations Market Size by Country (2021-2026)
  13. 7.4.3 North America External Anti-infective Preparations Market Size by Country (2027-2032)
  14. 7.4.4 North America External Anti-infective Preparations Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe External Anti-infective Preparations Market Size (2021-2032)
  2. 8.2 Europe External Anti-infective Preparations Market Size by Type
  3. 8.2.1 Europe External Anti-infective Preparations Market Size by Type (2021-2026)
  4. 8.2.2 Europe External Anti-infective Preparations Market Size by Type (2027-2032)
  5. 8.2.3 Europe External Anti-infective Preparations Market Share by Type (2021-2032)
  6. 8.3 Europe External Anti-infective Preparations Market Size by Application
  7. 8.3.1 Europe External Anti-infective Preparations Market Size by Application (2021-2026)
  8. 8.3.2 Europe External Anti-infective Preparations Market Size by Application (2027-2032)
  9. 8.3.3 Europe External Anti-infective Preparations Market Share by Application (2021-2032)
  10. 8.4 Europe External Anti-infective Preparations Market Size by Country
  11. 8.4.1 Europe External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe External Anti-infective Preparations Market Size by Country (2021-2026)
  13. 8.4.3 Europe External Anti-infective Preparations Market Size by Country (2027-2032)
  14. 8.4.4 Europe External Anti-infective Preparations Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China External Anti-infective Preparations Market Size (2021-2032)
  2. 9.2 China External Anti-infective Preparations Market Size by Type
  3. 9.2.1 China External Anti-infective Preparations Market Size by Type (2021-2026)
  4. 9.2.2 China External Anti-infective Preparations Market Size by Type (2027-2032)
  5. 9.2.3 China External Anti-infective Preparations Market Share by Type (2021-2032)
  6. 9.3 China External Anti-infective Preparations Market Size by Application
  7. 9.3.1 China External Anti-infective Preparations Market Size by Application (2021-2026)
  8. 9.3.2 China External Anti-infective Preparations Market Size by Application (2027-2032)
  9. 9.3.3 China External Anti-infective Preparations Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia External Anti-infective Preparations Market Size (2021-2032)
  2. 10.2 Asia External Anti-infective Preparations Market Size by Type
  3. 10.2.1 Asia External Anti-infective Preparations Market Size by Type (2021-2026)
  4. 10.2.2 Asia External Anti-infective Preparations Market Size by Type (2027-2032)
  5. 10.2.3 Asia External Anti-infective Preparations Market Share by Type (2021-2032)
  6. 10.3 Asia External Anti-infective Preparations Market Size by Application
  7. 10.3.1 Asia External Anti-infective Preparations Market Size by Application (2021-2026)
  8. 10.3.2 Asia External Anti-infective Preparations Market Size by Application (2027-2032)
  9. 10.3.3 Asia External Anti-infective Preparations Market Share by Application (2021-2032)
  10. 10.4 Asia External Anti-infective Preparations Market Size by Country
  11. 10.4.1 Asia External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia External Anti-infective Preparations Market Size by Country (2021-2026)
  13. 10.4.3 Asia External Anti-infective Preparations Market Size by Country (2027-2032)
  14. 10.4.4 Asia External Anti-infective Preparations Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa External Anti-infective Preparations Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa External Anti-infective Preparations Market Size by Type
  3. 11.2.1 South America, Middle East & Africa External Anti-infective Preparations Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa External Anti-infective Preparations Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa External Anti-infective Preparations Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa External Anti-infective Preparations Market Size by Application
  7. 11.3.1 South America, Middle East & Africa External Anti-infective Preparations Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa External Anti-infective Preparations Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa External Anti-infective Preparations Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa External Anti-infective Preparations Market Size by Country
  11. 11.4.1 South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa External Anti-infective Preparations Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa External Anti-infective Preparations Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst